Vor Biopharma (VOR) Research & Development (2020 - 2026)

Vor Biopharma (VOR) has 7 years of Research & Development data on file, last reported at $17.6 million in Q1 2026.

• Research & Development for Q1 2026 came in at $17.6 million, down 34.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $312.4 million (up 226.5% YoY), and the FY2025 annual result was $321.5 million, up 244.58% from the prior year.
• Research & Development eased to $17.6 million in Q1 2026 per VOR's latest filing, from $19.2 million in the prior quarter.
• Over five years, Research & Development peaked at $261.5 million in Q2 2025 and troughed at $14.1 million in Q3 2025.
• A 5-year average of $34.8 million and a median of $21.8 million in 2024 frame the typical range for Research & Development.
• On a YoY basis, Research & Development climbed as much as 1098.27% in 2025 and fell as far as 35.18% in 2025.
• A 5-year view of Research & Development shows it stood at $17.1 million in 2022, then grew by 22.48% to $20.9 million in 2023, then gained by 21.3% to $25.3 million in 2024, then retreated by 24.29% to $19.2 million in 2025, then fell by 8.31% to $17.6 million in 2026.
• Business Quant data shows VOR's Research & Development at $17.6 million in Q1 2026, $19.2 million in Q4 2025, and $14.1 million in Q3 2025.